CVS Health Co. (NYSE:CVS – Get Free Report)’s share price fell 0.1% during trading on Wednesday . The stock traded as low as $52.34 and last traded at $53.08. 2,169,597 shares traded hands during mid-day trading, a decline of 84% from the average session volume of 13,347,702 shares. The stock had previously closed at $53.15.
Analyst Upgrades and Downgrades
A number of equities research analysts recently weighed in on the stock. Wells Fargo & Company raised shares of CVS Health from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $60.00 to $66.00 in a research report on Monday, November 18th. Royal Bank of Canada reduced their price target on CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a report on Friday, November 15th. TD Cowen increased their price target on shares of CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a report on Monday, November 25th. Barclays lowered their price target on CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a report on Thursday, November 7th. Finally, StockNews.com lowered CVS Health from a “hold” rating to a “sell” rating in a research note on Thursday, November 14th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat, CVS Health has a consensus rating of “Moderate Buy” and a consensus price target of $68.71.
View Our Latest Stock Report on CVS Health
CVS Health Stock Up 0.5 %
CVS Health (NYSE:CVS – Get Free Report) last issued its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The business had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. During the same quarter in the previous year, the company posted $2.21 earnings per share. CVS Health’s revenue for the quarter was up 6.3% compared to the same quarter last year. On average, sell-side analysts expect that CVS Health Co. will post 5.22 EPS for the current fiscal year.
CVS Health Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be paid a dividend of $0.665 per share. The ex-dividend date is Thursday, January 23rd. This represents a $2.66 annualized dividend and a dividend yield of 4.98%. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently bought and sold shares of the company. MidAtlantic Capital Management Inc. acquired a new position in shares of CVS Health in the 3rd quarter worth approximately $25,000. Ridgewood Investments LLC lifted its position in CVS Health by 255.7% during the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 450 shares in the last quarter. Livelsberger Financial Advisory bought a new position in shares of CVS Health in the third quarter worth about $31,000. Legacy Investment Solutions LLC acquired a new position in shares of CVS Health during the third quarter worth approximately $31,000. Finally, Reston Wealth Management LLC bought a new stake in shares of CVS Health during the third quarter valued at approximately $32,000. Institutional investors and hedge funds own 80.66% of the company’s stock.
CVS Health Company Profile
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Featured Articles
- Five stocks we like better than CVS Health
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Oracle Announces Game-Changing News for the AI Industry
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Netflix Adds 19 Million Subscribers, Growth Is Far For Over
- The 3 Best Retail Stocks to Shop for in August
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.